Influence of sample matrix and storage on BNP measurement on the Bayer Advia Centaur

Journal of Clinical Laboratory Analysis

Volumn 21, Issue 5, 2007, Pages 293-297

  Lippi, Giuseppe ^a,c   Fortunato, Antonio ^b   Salvagno, Gian Luca ^a   Montagnana, Martina ^a   Soffiati, Giuliano ^b   Guidi, Gian Cesare ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b SAN BORTOLO HOSPITAL   (Italy)

^c UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

B type natriuretic peptide; Natriuretic peptides; Preanalytical variability; Storage

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; EDETIC ACID; HEPARIN;

ARTICLE; BLOOD SAMPLING; CASE REPORT; CLINICAL LABORATORY; CONGESTIVE HEART FAILURE; HUMAN; LABORATORY TEST; MEASUREMENT; PLASMA; SERUM;

BLOOD PRESERVATION; BLOOD SPECIMEN COLLECTION; HUMANS; NATRIURETIC PEPTIDE, BRAIN; REPRODUCIBILITY OF RESULTS;

TETRA;

EID: 35048877546     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.20187     Document Type: Article

References (23)

1. Cowie M, Mendez G. BNP and congestive heart failure. Prog Cardiovasc Dis 2002;44:293-321.
2. Mair J, Hammerer-Lercher A, Puschendorf D. The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure. Clin Chem Lab Med 2001;39:571-588.
3. Troughton RW, Richards AM. BNP for clinical monitoring of heart failure. Heart Fail Clin 2006;2:333-343.
4. Clerico A, Fontana M, Zyw L, Passino C, Emdin M. Comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP immunoassays in chronic and acute heart failure: a systematic review. Clin Chem 2007;53:813-822.
5. Sanz MP, Borque L, Rus A, Vicente B, Ramirez Y, Lasa L. Comparison of BNP and NT-proBNP assays in the approach to the emergency diagnosis of acute dyspnea. J Clin Lab Anal 2006;20:227-232.
6. Kragelund C, Gronning B, Kober L, Hildebrandt P, Steffensen R. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. N Engl J Med 2005;352:666-675.
7. Burke MA, Cotts WG. Interpretation of B-type natriuretic peptide in cardiac disease and other comorbid conditions. Heart Fail Rev 2007;12:23-36.
8. van der Merwe DE, Henley R, Lane G, et al. Effect of different sample types and stability after blood collection of N-terminal pro-B-type natriuretic peptide as measured with Roche Elecsys System [Letter]. Clin Chem 2004;50:779-780.
9. Shimizu H, Aono K, Masuta K, Asada H, Misaki A, Teraoka H. Degradation of human brain natriuretic peptide (BNP) by contact activation of blood coagulation system. Clin Chim Acta 2001;305:181-186.
10. Shimizu H, Masuta K, Aono K, et al. Molecular forms of human brain natriuretic peptide in plasma. Clin Chim Acta 2002;316:129-135.
11. Tsuji T, Imagawa K, Masuda H, et al. Stabilization of human brain natriuretic peptide in blood samples. Clin Chem 1994;40:672-673.
12. Clerico A, Iervasi G, Del Chicca MG, et al. Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure. J Endocrinol Invest 1998;21:170-179.
13. Banfi G, Salvagno GL, Lippi G. The role of ethylenediamine tetraacetic acid (EDTA) as in vitro anticoagulant for diagnostic purposes. Clin Chem Lab Med 2007;45:565-576.
14. Wu AH, Packer M, Smith A, et al. Analytical and clinical evaluation of the Bayer ADVIA Centaur automated B-type natriuretic peptide assay in patients with heart failure: a multisite study. Clin Chem 2004;50:867-873.
15. Wu AH. Serial testing of B-type natriuretic peptide and NTpro-BNP for monitoring therapy of heart failure: the role of biologic variation in the interpretation of results. Am Heart J 2006;152:828-834.
16. Morrow DA, de Lemos JA, Blazing MA, et al. Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery disease. JAMA 2005;294:2866-2871.
17. Kwan G, Isakson SR, Beede J, Clopton P, Maisel AS, Fitzgerald RL. Short-term serial sampling of natriuretic peptides in patients presenting with chest pain. J Am Coll Cardiol 2007;49:1186-1192.
18. Gobinet-Georges A, Valli N, Filliatre H, Dubernet MF, Dedeystere O, Bordenave L. Stability of brain natriuretic peptide (BNP) in human whole blood and plasma. Clin Chem Lab Med 2000;38:519-523.
19. Buckley MG, Marcus NJ, Yacoub MH. Cardiac peptide stability, aprotinin and room temperature: importance for assessing cardiac function in clinical practice. Clin Sci 1999;97:689-695.
20. Dupuy AM, Terrier N, Dubois M, Boularan AM, Cristol JP. Heparin plasma sampling as an alternative to EDTA for BNP determination on the Access-Beckman Coulter - effect of storage at -20 degrees C. Clin Lab 2006;52:393-397.
21. Mueller T, Gegenhuber A, Dieplinger B, Poelz W, Haltmayer M. Long-term stability of endogenous B-type natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP) in frozen plasma samples. Clin Chem Lab Med 2004;42:942-944.
22. Yeo KT, Wu AH, Apple FS, et al. Multicenter evaluation of the Roche NT-proBNP assay and comparison to the Biosite Triage BNP assay. Clin Chim Acta 2003;338:107-115.
23. Lippi G, Salvagno GL, Montagnana M, Guidi GC. Measurement of Elecsys NT-proBNP in serum, K(2) EDTA and heparin plasma. Clin Biochem 2007;40:747-748.